The Acorn: Pharmaceuticals share much of the blame for rising drug costs

The Acorn: Pharmaceuticals share much of the blame for rising drug costs

Instead of simply acknowledging their pricing strategies, drug companies and their lobbyists have launched a finger pointing campaign at pharmacy benefit managers (PBMs).